IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT)

24 filings reported holding IOBT - IO Biotech, Inc. - Common stock, par value $0.001 per share as of Q3 2023.
IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,668,665 shares of 65,606,830 outstanding shares and own 45% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (6,173,439 shares), Novo Holdings A/S (5,747,067 shares), Samsara BioCapital, LLC (3,640,015 shares), ARMISTICE CAPITAL, LLC (2,148,000 shares), MARSHALL WACE, LLP (2,105,262 shares), Avoro Capital Advisors LLC (2,055,883 shares), Stonepine Capital Management, LLC (1,975,308 shares), BANK OF AMERICA CORP /DE/ (1,854,185 shares), PFM Health Sciences, LP (1,353,453 shares), and Alyeska Investment Group, L.P. (987,654 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.